期刊
INTERNATIONAL REVIEWS OF IMMUNOLOGY
卷 40, 期 5, 页码 319-329出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/08830185.2020.1840565
关键词
Autoimmunity; cancer; IL-27; immunotherapy
类别
资金
- Shiraz Institute for Cancer Research
IL-27 plays a crucial role in modulating inflammation by interacting with innate and adaptive immune cells. It has dual functions of promoting inflammation through the activation of certain immune cells, while also suppressing inflammation through cell death and suppression of effector cells. Additionally, recent studies have shown its potential in both antitumor activity and promoting tumor cell proliferation and survival.
Interleukin (IL)-27, a member of the IL-6/IL-12 family, has an important role in modulating inflammation in partnership with innate and adaptive immune cells. IL-27 binding to IL-27R starts downstream signaling based on the target cells. It can instigate inflammation by inducing CD4(+) T cell proliferation, Th1 polarization, cytotoxic T cell activation, generation of the natural killer cell, and macrophage and dendritic cell activation. However, by inducing programmed cell death and suppression of effector cells, IL-27 can suppress inflammation and return the immune response to hemostasis. Altogether, IL-27 displays multifaceted dual functions, which may result in either pro- or anti-inflammatory effects. Recent investigations indicated the antitumor activity of IL-27 via inducing Th1, and CTL responses and generating NK cells. On the other hand, IL-27 also can promote tumor cells' proliferation, survival, and angiogenesis. In the present review, we'll discuss recent advances concerning the role of IL-27 in inflammatory diseases such as infections, autoimmune diseases with a focus on cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据